Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Posts 10 Percent Organic Revenue Growth in Q1

NEW YORK (GenomeWeb News) – Qiagen reported after the close of the market on Monday that its first-quarter revenues rose 62 percent, or 10 percent on an organic basis.
The firm generated revenues of $207.1 million for the three-month period ended March 31, compared to revenues of $127.9 million for the first quarter of 2007. This year’s Q1 results include revenue contributions from eGene and Digene, which Qiagen acquired during the past year.
Its North American sales rose 106 percent and accounted for 50 percent of the firm’s revenues, while European sales climbed 21 percent and accounted for 38 percent of revenues.
Qiagen posted net income of $20.3 million, or $.10 per share, compared to a profit of $19.9 million, or $.13 per share, in last year’s first quarter. The 2008 first quarter results include $12.4 million of acquisition, integration, and acquisition-related intangible charges, compared to $1.4 million of such costs in the comparable period a year ago.
On an adjusted basis —excluding acquisition, integration, and restructuring-related charges — Qiagen’s net earnings were up 63 percent at $36.9 million versus $22.6 million a year earlier.
The company’s R&D expenses nearly doubled to $21.2 million from $11.5 million year over year, while its SG&A costs climbed 76.2 percent to $75.4 million from $42.8 million.
Qiagen finished the quarter with $351.6 million in cash and cash equivalents.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.